Dapagliflozin and chiglitazar combination enhanced myocardial energy metabolism in high‐fat diet‐fed mice

Documenti analoghi

• Accelerated onset of diabetes in non‐obese diabetic mice fed a refined high‐fat diet
  di: Heidi M. Batdorf, et al.
  Pubblicazione: (2024)
• Digitally enhanced ketogenic diet versus low‐fat diet for cardio‐renal‐metabolic health in a predominantly Hispanic adult population with overweight or obesity: Pilot randomised clinical trial
  di: Yan Du, et al.
  Pubblicazione: (2025)
• Efficacy and safety of chiglitazar add‐on to metformin in type 2 diabetes mellitus ( RECAM study)
  di: Leili Gao, et al.
  Pubblicazione: (2025)
• Hepatocyte‐specific RAP1B deficiency ameliorates high‐fat diet‐induced obesity and liver inflammation in mice
  di: Yinxu Fu, et al.
  Pubblicazione: (2025)
• The GPR40 novel agonist SZZ15 ‐11 improves non‐alcoholic fatty liver disease by activating the AMPK pathway and restores metabolic homeostasis in diet‐induced obese mice
  di: Lei Lei, et al.
  Pubblicazione: (2024)